Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
autoimmune disorders
boston
boston blog main
boston top stories
clinical trials
deals
life sciences
national blog main
alexion pharmaceuticals
allosteric
alzheimer's disease
amyloid
amyotrophic lateral sclerosis (als)
atlas venture
atopic dermatitis
biomedicine
brace pharma
brain
cleva pharma
complement system
drug discovery
dupilumab
extreme
fda
generalized myasthenia gravis
glaxosmithkline
hotspot therapeutics
image manipulation
immune-mediated necrotizing myopathy
investing
jonathan montagu
medicine
metabolic diseases
mrl ventures fund
national top stories
neuroscience
ra pharmaceuticals
rare disease drugs
reproducibility crisis
What
disease
3
×
potential
3
×
medicines
accusing
address
adds
ago
allosteric
alternative
alzheimer's
alzheimer’s
amyloid
appeared
autoimmune
bombshell
candidate
clinic
deal
deliberate
drug
elusive
expensive
extremetech
fabrication
fraud
hotspot
hypothesis
imperil
investigation
lead
molecules
new
path
pharma
pharmaceuticals
post
prestigious
ra
report
research
Language
unset
Current search:
biotech
×
disease
×
potential
×
@extremetech.com
1 year ago
Potential Research Fabrication Bombshell Threatens Amyloid Theory of Alzheimer’s Disease
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
